Amgen (AMG) is a biotechnology company that manufactures and markets human therapeutics. It has a customer support number and headquarters in Thousand Oaks, California. The company was founded in 1980 and was the first to market a recombinant human insulin product. Amgen products are used to treat a variety of conditions, including cancer, anemia, and kidney disease.
Amgen (AMG) phone number.
You can reach Amgen by calling their customer service line at (800) 223-2334.
Amgen (AMG) support.
On January 9, 2019, Amgen announced that it would be providing support for the development and launch of a new open-source blockchain platform called "Amallet." The platform will allow companies to create and manage their own blockchain networks, and will provide a suite of tools and services to help companies navigate the nascent blockchain space.
Amgen is not the only company to announce support for Amallet. In December 2018, Toyota (TM) announced that it was also partnering with Amallet to create a network for sharing data between its various businesses. Other notable partners include IBM (IBM) and Intel (INTC).
Given Amgen's history in the pharmaceutical industry, its participation in Amallet is particularly noteworthy. The blockchain platform provides a way for companies to manage and track transactions and interactions across their networks more efficiently, which could ultimately lead to lower costs and improved transparency.
Amgen (AMG) customer care.
AMG customer service is available to assist you with any questions or concerns you may have. To reach customer service, call 1-800-227-2334 from within the United States or Canada, or +1-800-243-2001 from outside the United States or Canada. You can also reach customer service online via the AMG website.
What is Amgen (AMG)?
Amgen Inc. is a biotechnology company focused on developing innovative medicines to help patients with serious diseases. The company's products include therapies for cancer, cardiac disease, arthritis, and multiple sclerosis. Amgen also develops tools and technologies to improve the diagnosis and treatment of these diseases. The company has research and development facilities in California, Massachusetts, and Israel. Amgen is traded on the NASDAQ stock exchange under the symbol AMGN.
Amgen (AMG) headquarters.
In the early 1990s, AMG was a small startup company in California. It was founded by Bob Young and Gary Hitzig, and it specialized in the development of software for the pharmaceutical industry.
In 1997, AMG merged with Pharmacia Corporation, and then merged with Eli Lilly and Company in 2000. As a result of these mergers, AMG became one of the largest software companies in the world.
In 2006, AMG acquired Genentech's oncology business, which made it one of the world's largest cancer companies.
In 2007, AMG acquired MedImmune, a leading biotechnology company.
In 2008, AMG acquired Immunomedics, a leading producer of vaccines and therapeutics.
In 2009, AMG acquired Questcor, a leading provider of diagnostic tests.
In 2010, AMG acquired Gambro Corporation, an international health care company.
In 2012, AMG acquired BioMarin Pharmaceutical Inc., a leading developer and manufacturer of biologics for human use.
In 2013, AMG acquired Idera Therapeutics, a biopharmaceutical company focused on developing innovative therapies for cancer.
In 2014, AMG acquired Vertex Pharmaceuticals Inc., a leading developer and manufacturer of biologic drugs for the treatment of several types of cancer.
In 2015, AMG acquired ImmunoCellular Therapeutics Inc., a company focused on the development of novel immunotherapies.
In 2016, AMG acquired Juno Therapeutics Inc., a company focused on the development of novel therapeutics to treat rare diseases.
In 2017, AMG acquired Cadence Pharmaceuticals Inc., a company focused on the development of novel therapeutics to treat cancer.